Geometric Deep learning Prioritization and Validation of Cannabis Phytochemicals as Anti-HCV Non-nucleoside Direct-acting Inhibitors
Introduction: The rate of acute hepatitis C increased by 7% between 2020 and 2021, after the number of cases doubled between 2014 and 2020. With the current adoption of pan-genotypic HCV therapy, there is a need for improved availability and accessibility of this therapy. However, double and triple...
Saved in:
| Main Authors: | Ssemuyiga Charles, Mulumba Pius Edgar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Biomedical Engineering and Computational Biology |
| Online Access: | https://doi.org/10.1177/11795972241306881 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry
by: Tyng-Yuan Jang, et al.
Published: (2025-08-01) -
HCV-related chronic kidney disease in the era of new direct-acting antivirals regimens
by: Jakub Janczura, et al.
Published: (2025-08-01) -
Exploring Anti-Inflammatory and Anti-Tyrosinase Potentials and Phytochemical Profiling of <i>Cannabis sativa</i> Stems Byproducts
by: Pannita Kongtananeti, et al.
Published: (2025-06-01) -
Diagnostic approach to elucidate the efficacy and side effects of direct-acting antivirals in HCV infected patients
by: Sonia Younas, et al.
Published: (2021-10-01) -
Threshold value of the anti-HCV test in the diagnosis of HCV infection
by: Özlem Kirişci, et al.
Published: (2019-10-01)